Wendy Stock to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Wendy Stock has written about Xenograft Model Antitumor Assays.
Connection Strength
0.050
-
DNTT-mediated DNA damage response drives inotuzumab ozogamicin resistance in B-cell acute lymphoblastic leukemia. Blood. 2025 Mar 13; 145(11):1182-1194.
Score: 0.050
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.